DBVT - DBV Technologies logo

DBV Technologies

DBVT

DBV Technologies develops epicutaneous immunotherapy products for food allergies, focusing on Viaskin Peanut for peanut allergies and Viaskin Milk for cow's milk protein allergy. It also explores treatments for celiac disease and autoimmune conditions.

⚕️ Healthcare NASDAQ Listed 2014 € EUR
$1,000 invested 10 years ago →$31today

Score Overview

1 Year
Score
Net Growth-29.62%
Net TrendShrank
Net Income Consistency—
Rev Growth-100.00%
Rev TrendShrank
Revenue Consistency—
5 Years
Score3.8
Net Growth7.62%
Net Trend60%
Net Income Consistency—
Rev Growth-100.00%
Rev Trend20%
Revenue Consistency—
10 Years
Score
Net Growth-203.80%
Net Trend50%
Net Income Consistency
Rev Growth-100.00%
Rev Trend50%
Revenue Consistency
All Time
Score
Net Growth-407.14%
Net Trend45%
Net Income Consistency
Rev Growth-100.00%
Rev Trend45%
Revenue Consistency

Explore the 2021 public Archive ranking →

Where DBV Technologies has ranked, year by year

Measure
Fundamentals Window

Showing 1 year ranking history by HDB Score.

Has not reached the top 50 on HDB Score in any year we have ranked.

  • DBVT

2020: 42.6% · 2021: 42.5% · free through 2021 · longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-01
$ 11.21—
1 Year2025-10-01
$ 10.0711.32%
5 Years2021-10-01
$ 47.80-76.55%
10 Years2016-09-30
$ 363.30-96.91%
All Time2014-10-22
$ 229.00-95.10%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in EUR

Year
2025€ 0.00-€ 147M€ 194M
2024€ 2M-€ 113M€ 32M
2023€ 15M-€ 72M€ 141M
2022€ 4M-€ 96M€ 209M
2021€ 5M-€ 97M€ 77M
2020€ 11M-€ 159M€ 196M
2019€ 14M-€ 172M€ 193M
2018€ 12M-€ 190M€ 167M
2017€ 11M-€ 177M€ 194M
2016€ 7M-€ 126M€ 282M
2015€ 220.85K-€ 48M€ 385M
IPO2014€ 256.58K-€ 29M€ 180M
DBVT - DBV Technologies logo

DBV Technologies fundamental performance

Between 2020 and 2025, revenue declined from € 11M to € 0.00 and net income went from -€ 159M to -€ 147M. Revenue increased in 1 of those 5 years; net income in 3.

Across DBV Technologies's full reported history, from 2014 to 2025, revenue declined from € 256.58K to € 0.00 and net income went from -€ 29M to -€ 147M. Revenue increased in 45% of the years measured; net income in 45%.

DBV Technologies currently holds a 5-year HDB Score of 3.8 out of 10. How the HDB Score is calculated.

Membership

Continue DBVT’s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,813 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year · Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies